SAN DIEGO, Sept. 3, 2019 /PRNewswire/ -- Inhibrx, Inc. (Inhibrx), a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates, announced today the completion of the dose escalation portion of its Phase 1 clinical trial of INBRX-109. INBRX-109 is a multivalent agonist of death receptor 5 (DR5) in development

SAN DIEGO, Sept. 3, 2019 /PRNewswire/ -- Aristea Therapeutics (Aristea), a clinical-stage drug development company developing novel therapies to treat serious inflammatory diseases, today announced the appointment of Nihar Bhakta, M.D. as Chief Medical Officer.  In his new role, Dr. Bhakta will be responsible for leading and expanding

AUSTIN, Texas, Sept. 3, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that Homi Shamir, President and Chief Executive Officer, will participate in an analyst-led fireside chat at the Morgan Stanley 17th Annual Global Healthcare Conference to be held September 9-11, 2019, in

ATLANTA, Sept. 3, 2019 /PRNewswire/ -- MedShape, Inc., the industry leader in orthopedic devices using advanced functional materials, announced today the launch of the DynaNail Mini™ Fusion System. Featuring MedShape's patented superelastic nickel titanium (NiTiNOL) technology, the DynaNail Mini is the first orthopaedic device designed specifically for

LAVAL, Quebec, Sept. 3, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it will reduce debt by approximately $200 million through the prepayment of senior secured term loans and the redemption of outstanding senior notes, using cash flow from operations. Bausch Healt

IRVINE, Calif., Sept. 3, 2019 /PRNewswire/ -- To help researchers improve data accuracy and cross-study comparisons, Zymo Research is providing complimentary microbiome standards and controls to researchers worldwide through

SAN DIEGO, Sept. 3, 2019 /PRNewswire/ -- Timed to coincide with Sepsis Awareness Month, Sepsis Alliance, the nation's first and leading sepsis organization, released today the results of its annual Sepsis Awareness Survey, conducted by Radius Global Market Research. The survey revealed that sepsis awareness remains at an all-time high of 65%, year over year. However

Company to showcase its innovative Alzheimer's, Parkinson's and ALS programs TORONTO and CAMBRIDGE, MA, Sept. 3, 2019 /PRNewswire/ - ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers im

DUBLIN, Sept. 3, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today it received U.S. Food and Drug Administration (FDA) approval for the use of Juvéderm VOLUMA® XC, a hyaluronic acid gel dermal filler, with a TSK STERiGLIDE™ cannula for cheek augmentation to correct age-related volume deficit in the mid-face in adults over 21. A can

Martin Bott steps down from the Board of DirectorsTSX:IN OTCQX:IMLFF VANCOUVER, Sept. 3, 2019 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis manufacturing technology for the prod